Brief: Oasmia Q3 Operating Loss Narrows To SEK 29.6 Mln
Nov 18 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* Q3 OPERATING LOSS WAS TSEK 29,572 (35,194
* Q3 NET LOSS AFTER TAX AMOUNTED TO TSEK -30,987 (-36,784)
Source text for Eikon: ID:nMFN79GZ8F
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO